Back to search

Article

N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication

2021-06-28

Abstract excerpt

<h4>ABSTRACT</h4> Effective therapeutics to inhibit the replication of SARS-CoV-2 in infected individuals are still under development. The nucleoside analogue N4-hydroxycytidine (NHC), also known as EIDD-1931, interferes with SARS-CoV-2 replication in cell culture. It is the active metabolite of the prodrug Molnupiravir (MK-4482), which is currently being evaluated for the treatment of COVID-19 in advanced clinic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
77c89f10-c9d7-56e9-b544-cc46abe7d080
DOI
10.1101/2021.06.28.450163
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replicationDOI 10.1101/2021.06.28.450163
Select a neighboring publication to make it the new centre.